Aripiprazole
Rank #49 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$373.1M
Total Cost
1,494,971
Total Claims
$373.1M
Total Cost
34,750
Prescribers
$250
Cost per Claim
170,006
Beneficiaries
1,947,280
30-Day Fills
$11K
Avg Cost/Provider
43
Avg Claims/Provider
Share of Medicare Part D Spending
0.14%
of total Medicare Part D spending
$373.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $373.1M total
🔎 Data Overview
Ranked #49 out of 500 drugs tracked by total cost. Aripiprazole represents a significant portion of Medicare drug spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Aripiprazole
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ileana Berman | Psychiatry | Attleboro, MA | 533 | $1.4M |
| 2 | Anissa Thomas | Nurse Practitioner | Birmingham, AL | 201 | $564K |
| 3 | Joanna Mulder | Nurse Practitioner | Valrico, FL | 195 | $546K |
| 4 | Joyce Vaughn | Nurse Practitioner | Flowood, MS | 183 | $524K |
| 5 | Manojbhai Patel | Psychiatry | Washington, PA | 180 | $497K |
| 6 | Tammy Lee | Nurse Practitioner | Mobile, AL | 172 | $493K |
| 7 | Erin Kletscher | Nurse Practitioner | Marshall, MN | 167 | $467K |
| 8 | Valerie Rumple | Nurse Practitioner | Fort Wayne, IN | 151 | $426K |
| 9 | Lorna Barte | Psychiatry | Camarillo, CA | 142 | $421K |
| 10 | Afiah Ahsan | Psychiatry | Huntington, WV | 148 | $416K |
| 11 | Hayng Sung Yang | Psychiatry & Neurology | Urbana, IL | 137 | $388K |
| 12 | Lakshmikantha Kumbla | Psychiatry | Greenville, AL | 135 | $385K |
| 13 | Joshua Eslami | Nurse Practitioner | Montgomery, AL | 131 | $379K |
| 14 | Ollie Combs | Nurse Practitioner | Madisonville, KY | 128 | $377K |
| 15 | Curtis Child | Nurse Practitioner | Las Vegas, NV | 141 | $373K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
| 48 | Insulin Detemir (Levemir Flexpen) | $376.5M | 548,216 |
| 49 | Aripiprazole (Aripiprazole) | $373.1M | 1,494,971 |
| 50 | Apalutamide (Erleada) | $369.2M | 24,956 |
| 51 | Secukinumab (Cosentyx Sensoready (2 Pens)) | $347.7M | 45,496 |
| 52 | Upadacitinib (Rinvoq) | $346.0M | 51,469 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology